Tianjin, China

Wenyan Niu

This inventor holds 1 USPTO granted patent. Top assignee: Tianjin Medical University. Active years: 2015.


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Diabetes Treatment by Wenyan Niu

Introduction

Wenyan Niu is an accomplished inventor based in Tianjin, China. He has made significant contributions to the field of medical science, particularly in the development of flavone derivatives for treating diabetes. His innovative work has the potential to improve the lives of many individuals suffering from this chronic condition.

Latest Patents

Wenyan Niu holds a patent for "Flavone derivatives and their preparative method and medical use." This patent describes flavone derivatives, their preparative methods, and their use as medicaments for treating diabetes. The structure of these derivatives is defined by specific chemical formulas, where Rand R can represent various functional groups. The pharmacological tests conducted indicate that these flavone derivatives can significantly increase glucose consumption in Hep-G2 cells, demonstrating insulin resistance activity. Furthermore, they promote the translocation of glucose transporter 4 in skeletal muscle cells, enhancing glucose intake and utilization.

Career Highlights

Wenyan Niu is affiliated with Tianjin Medical University, where he conducts his research and development work. His dedication to advancing medical science is evident through his innovative approaches to diabetes treatment. His research has garnered attention for its potential impact on therapeutic strategies for managing diabetes.

Collaborations

Wenyan Niu collaborates with esteemed colleagues, including Meina Jin and Lihuan Shi. Their combined expertise contributes to the advancement of research in the field of diabetes treatment.

Conclusion

Wenyan Niu's contributions to the development of flavone derivatives represent a significant advancement in diabetes treatment. His innovative research holds promise for improving therapeutic options for individuals affected by this condition.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…